CORZIDE (Pfizer Laboratories Div Pfizer Inc)


Welcome to the PulseAid listing for the CORZIDE drug offered from Pfizer Laboratories Div Pfizer Inc. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Pfizer Laboratories Div Pfizer Inc
NON-PROPRIETARY NAME: nadolol and bendroflumethiazide
SUBSTANCE NAME: NADOLOL; BENDROFLUMETHIAZIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1983-05-25
END MARKETING DATE: 0000-00-00


CORZIDE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCORZIDE from Pfizer Laboratories Div Pfizer Inc
LABELER NAME: Pfizer Laboratories Div Pfizer Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 40; 5(mg/1; mg/1)
START MARKETING DATE: 1983-05-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60793-283_6a0ac6f2-a99a-4985-92ea-9fd16b37c15c
PRODUCT NDC: 60793-283
APPLICATION NUMBER: NDA018647

Other NADOLOL; BENDROFLUMETHIAZIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Impax GenericsNadolol and Bendroflumethiazide
Pfizer Laboratories Div Pfizer IncCORZIDE